nodes	percent_of_prediction	percent_of_DWPC	metapath
Progesterone—ABCC1—Vemurafenib—skin cancer	0.0876	0.125	CbGbCtD
Progesterone—ABCC1—Dactinomycin—skin cancer	0.0582	0.0834	CbGbCtD
Progesterone—CYP1A2—Imiquimod—skin cancer	0.0441	0.0632	CbGbCtD
Progesterone—CYP1B1—Docetaxel—skin cancer	0.0423	0.0606	CbGbCtD
Progesterone—CYP1A1—Dacarbazine—skin cancer	0.0415	0.0594	CbGbCtD
Progesterone—CYP2C8—Vismodegib—skin cancer	0.0395	0.0566	CbGbCtD
Progesterone—CYP2C19—Vismodegib—skin cancer	0.0331	0.0475	CbGbCtD
Progesterone—ABCC1—Docetaxel—skin cancer	0.0301	0.0431	CbGbCtD
Progesterone—CYP2A6—Fluorouracil—skin cancer	0.0285	0.0408	CbGbCtD
Progesterone—CYP2C9—Vismodegib—skin cancer	0.0275	0.0395	CbGbCtD
Progesterone—ABCB1—Vismodegib—skin cancer	0.0267	0.0383	CbGbCtD
Progesterone—CYP1A2—Vemurafenib—skin cancer	0.0242	0.0346	CbGbCtD
Progesterone—CYP3A4—Temozolomide—skin cancer	0.0231	0.0331	CbGbCtD
Progesterone—CYP3A4—Imiquimod—skin cancer	0.0231	0.0331	CbGbCtD
Progesterone—CYP2D6—Vemurafenib—skin cancer	0.0199	0.0285	CbGbCtD
Progesterone—CYP1A2—Dacarbazine—skin cancer	0.0185	0.0265	CbGbCtD
Progesterone—CYP3A4—Vismodegib—skin cancer	0.016	0.0229	CbGbCtD
Progesterone—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.0149	0.0213	CbGbCtD
Progesterone—CYP3A7—Docetaxel—skin cancer	0.0149	0.0213	CbGbCtD
Progesterone—ABCB1—Dactinomycin—skin cancer	0.014	0.0201	CbGbCtD
Progesterone—CYP2C8—Fluorouracil—skin cancer	0.014	0.0201	CbGbCtD
Progesterone—CYP3A4—Vemurafenib—skin cancer	0.0127	0.0181	CbGbCtD
Progesterone—CYP3A5—Docetaxel—skin cancer	0.0111	0.016	CbGbCtD
Progesterone—CYP1A2—Fluorouracil—skin cancer	0.0109	0.0156	CbGbCtD
Progesterone—CYP2C9—Fluorouracil—skin cancer	0.00979	0.014	CbGbCtD
Progesterone—ABCB1—Docetaxel—skin cancer	0.00725	0.0104	CbGbCtD
Progesterone—AR—scrotum—skin cancer	0.00691	0.109	CbGeAlD
Progesterone—CYP3A4—Docetaxel—skin cancer	0.00434	0.00622	CbGbCtD
Progesterone—SHBG—hindlimb—skin cancer	0.00328	0.0517	CbGeAlD
Progesterone—AR—penis—skin cancer	0.00312	0.0491	CbGeAlD
Progesterone—PGR—blood vessel—skin cancer	0.00141	0.0222	CbGeAlD
Progesterone—CYP1B1—hair follicle—skin cancer	0.00127	0.0199	CbGeAlD
Progesterone—CYP1A1—skin epidermis—skin cancer	0.00125	0.0197	CbGeAlD
Progesterone—ABCC1—hair follicle—skin cancer	0.00114	0.0179	CbGeAlD
Progesterone—SHBG—neck—skin cancer	0.00112	0.0176	CbGeAlD
Progesterone—ESR1—blood vessel—skin cancer	0.0011	0.0174	CbGeAlD
Progesterone—NR3C2—nipple—skin cancer	0.0011	0.0173	CbGeAlD
Progesterone—CYP17A1—connective tissue—skin cancer	0.00108	0.017	CbGeAlD
Progesterone—NR3C1—nerve—skin cancer	0.00104	0.0163	CbGeAlD
Progesterone—PGR—nipple—skin cancer	0.00102	0.0161	CbGeAlD
Progesterone—SLC22A3—nipple—skin cancer	0.000934	0.0147	CbGeAlD
Progesterone—SIGMAR1—nipple—skin cancer	0.000903	0.0142	CbGeAlD
Progesterone—SLC10A1—female reproductive system—skin cancer	0.000872	0.0137	CbGeAlD
Progesterone—AR—nipple—skin cancer	0.000813	0.0128	CbGeAlD
Progesterone—SHBG—connective tissue—skin cancer	0.000803	0.0126	CbGeAlD
Progesterone—ESR1—neck—skin cancer	0.00079	0.0124	CbGeAlD
Progesterone—NR3C2—connective tissue—skin cancer	0.000778	0.0123	CbGeAlD
Progesterone—ABCC1—nipple—skin cancer	0.000772	0.0122	CbGeAlD
Progesterone—OPRK1—female reproductive system—skin cancer	0.000768	0.0121	CbGeAlD
Progesterone—CYP17A1—female reproductive system—skin cancer	0.00076	0.012	CbGeAlD
Progesterone—SLC10A1—head—skin cancer	0.000729	0.0115	CbGeAlD
Progesterone—PGR—connective tissue—skin cancer	0.000724	0.0114	CbGeAlD
Progesterone—PGR—epithelium—skin cancer	0.000687	0.0108	CbGeAlD
Progesterone—SLC22A3—connective tissue—skin cancer	0.000662	0.0104	CbGeAlD
Progesterone—OPRK1—head—skin cancer	0.000642	0.0101	CbGeAlD
Progesterone—NR3C2—mammalian vulva—skin cancer	0.000641	0.0101	CbGeAlD
Progesterone—CYP17A1—head—skin cancer	0.000635	0.00999	CbGeAlD
Progesterone—CYP1A2—nipple—skin cancer	0.000615	0.00969	CbGeAlD
Progesterone—CYP1B1—connective tissue—skin cancer	0.000609	0.00958	CbGeAlD
Progesterone—CYP1A1—nipple—skin cancer	0.000607	0.00955	CbGeAlD
Progesterone—NR3C1—nipple—skin cancer	0.000589	0.00927	CbGeAlD
Progesterone—NR3C1—neck—skin cancer	0.000583	0.00917	CbGeAlD
Progesterone—AR—connective tissue—skin cancer	0.000576	0.00908	CbGeAlD
Progesterone—SHBG—female reproductive system—skin cancer	0.000566	0.00892	CbGeAlD
Progesterone—ESR1—connective tissue—skin cancer	0.000566	0.00891	CbGeAlD
Progesterone—CYP1B1—skin of body—skin cancer	0.00055	0.00865	CbGeAlD
Progesterone—NR3C2—female reproductive system—skin cancer	0.000549	0.00864	CbGeAlD
Progesterone—AR—epithelium—skin cancer	0.000547	0.00862	CbGeAlD
Progesterone—SLC22A3—mammalian vulva—skin cancer	0.000545	0.00859	CbGeAlD
Progesterone—ESR1—epithelium—skin cancer	0.000537	0.00846	CbGeAlD
Progesterone—PGR—lymphoid tissue—skin cancer	0.000529	0.00833	CbGeAlD
Progesterone—SIGMAR1—mammalian vulva—skin cancer	0.000527	0.0083	CbGeAlD
Progesterone—AR—skin of body—skin cancer	0.000521	0.0082	CbGeAlD
Progesterone—PGR—female reproductive system—skin cancer	0.00051	0.00803	CbGeAlD
Progesterone—AR—mammalian vulva—skin cancer	0.000475	0.00747	CbGeAlD
Progesterone—SLC22A3—female reproductive system—skin cancer	0.000467	0.00735	CbGeAlD
Progesterone—NR3C2—head—skin cancer	0.000459	0.00722	CbGeAlD
Progesterone—ABCC1—mammalian vulva—skin cancer	0.000451	0.0071	CbGeAlD
Progesterone—CYP1B1—lymphoid tissue—skin cancer	0.000445	0.00701	CbGeAlD
Progesterone—CYP17A1—lymph node—skin cancer	0.000444	0.007	CbGeAlD
Progesterone—ABCB1—blood vessel—skin cancer	0.000436	0.00686	CbGeAlD
Progesterone—CYP1B1—female reproductive system—skin cancer	0.000429	0.00676	CbGeAlD
Progesterone—PGR—head—skin cancer	0.000426	0.00671	CbGeAlD
Progesterone—AR—lymphoid tissue—skin cancer	0.000421	0.00664	CbGeAlD
Progesterone—NR3C1—connective tissue—skin cancer	0.000418	0.00657	CbGeAlD
Progesterone—ESR1—lymphoid tissue—skin cancer	0.000414	0.00652	CbGeAlD
Progesterone—CYP1A1—epithelium—skin cancer	0.000409	0.00643	CbGeAlD
Progesterone—SLC22A1—head—skin cancer	0.000408	0.00643	CbGeAlD
Progesterone—AR—female reproductive system—skin cancer	0.000407	0.0064	CbGeAlD
Progesterone—ESR1—female reproductive system—skin cancer	0.000399	0.00628	CbGeAlD
Progesterone—NR3C1—epithelium—skin cancer	0.000396	0.00624	CbGeAlD
Progesterone—SLC22A3—head—skin cancer	0.00039	0.00614	CbGeAlD
Progesterone—CYP1A1—skin of body—skin cancer	0.000389	0.00612	CbGeAlD
Progesterone—NR3C1—skin of body—skin cancer	0.000377	0.00594	CbGeAlD
Progesterone—CYP1B1—head—skin cancer	0.000359	0.00565	CbGeAlD
Progesterone—CYP1A1—mammalian vulva—skin cancer	0.000354	0.00558	CbGeAlD
Progesterone—NR3C1—mammalian vulva—skin cancer	0.000344	0.00541	CbGeAlD
Progesterone—AR—head—skin cancer	0.00034	0.00535	CbGeAlD
Progesterone—ESR1—head—skin cancer	0.000333	0.00525	CbGeAlD
Progesterone—CYP2C8—female reproductive system—skin cancer	0.000329	0.00518	CbGeAlD
Progesterone—NR3C2—lymph node—skin cancer	0.000321	0.00506	CbGeAlD
Progesterone—NR3C1—lymphoid tissue—skin cancer	0.000305	0.00481	CbGeAlD
Progesterone—CYP1A1—female reproductive system—skin cancer	0.000303	0.00478	CbGeAlD
Progesterone—PGR—lymph node—skin cancer	0.000299	0.0047	CbGeAlD
Progesterone—NR3C1—female reproductive system—skin cancer	0.000294	0.00464	CbGeAlD
Progesterone—CYP2C9—female reproductive system—skin cancer	0.000292	0.0046	CbGeAlD
Progesterone—SLC22A3—lymph node—skin cancer	0.000273	0.0043	CbGeAlD
Progesterone—SIGMAR1—lymph node—skin cancer	0.000264	0.00416	CbGeAlD
Progesterone—CYP1A1—head—skin cancer	0.000254	0.00399	CbGeAlD
Progesterone—CYP1B1—lymph node—skin cancer	0.000251	0.00395	CbGeAlD
Progesterone—NR3C1—head—skin cancer	0.000246	0.00387	CbGeAlD
Progesterone—AR—lymph node—skin cancer	0.000238	0.00374	CbGeAlD
Progesterone—ESR1—lymph node—skin cancer	0.000233	0.00368	CbGeAlD
Progesterone—ABCC1—lymph node—skin cancer	0.000226	0.00356	CbGeAlD
Progesterone—CYP3A4—female reproductive system—skin cancer	0.000223	0.00351	CbGeAlD
Progesterone—CYP2D6—female reproductive system—skin cancer	0.000219	0.00345	CbGeAlD
Progesterone—ABCB1—epithelium—skin cancer	0.000212	0.00334	CbGeAlD
Progesterone—Cardiac disorder—Temozolomide—skin cancer	0.000207	0.000929	CcSEcCtD
Progesterone—Haemoglobin—Fluorouracil—skin cancer	0.000206	0.000927	CcSEcCtD
Progesterone—Rhinitis—Fluorouracil—skin cancer	0.000206	0.000925	CcSEcCtD
Progesterone—Haemorrhage—Fluorouracil—skin cancer	0.000205	0.000922	CcSEcCtD
Progesterone—Dizziness—Vemurafenib—skin cancer	0.000205	0.00092	CcSEcCtD
Progesterone—Pharyngitis—Fluorouracil—skin cancer	0.000204	0.000915	CcSEcCtD
Progesterone—Angiopathy—Temozolomide—skin cancer	0.000202	0.000908	CcSEcCtD
Progesterone—Immune system disorder—Temozolomide—skin cancer	0.000201	0.000904	CcSEcCtD
Progesterone—Mediastinal disorder—Temozolomide—skin cancer	0.000201	0.000902	CcSEcCtD
Progesterone—Cough—Bleomycin—skin cancer	0.000201	0.000901	CcSEcCtD
Progesterone—Ill-defined disorder—Dactinomycin—skin cancer	0.000199	0.000894	CcSEcCtD
Progesterone—Anaemia—Dactinomycin—skin cancer	0.000198	0.00089	CcSEcCtD
Progesterone—Liver function test abnormal—Docetaxel—skin cancer	0.000198	0.000888	CcSEcCtD
Progesterone—Vomiting—Vemurafenib—skin cancer	0.000197	0.000885	CcSEcCtD
Progesterone—Alopecia—Temozolomide—skin cancer	0.000197	0.000885	CcSEcCtD
Progesterone—Chest pain—Bleomycin—skin cancer	0.000196	0.000879	CcSEcCtD
Progesterone—Myalgia—Bleomycin—skin cancer	0.000196	0.000879	CcSEcCtD
Progesterone—Rash—Vemurafenib—skin cancer	0.000195	0.000877	CcSEcCtD
Progesterone—Mental disorder—Temozolomide—skin cancer	0.000195	0.000877	CcSEcCtD
Progesterone—Dermatitis—Vemurafenib—skin cancer	0.000195	0.000877	CcSEcCtD
Progesterone—Hypersensitivity—Imiquimod—skin cancer	0.000195	0.000874	CcSEcCtD
Progesterone—Headache—Vemurafenib—skin cancer	0.000194	0.000872	CcSEcCtD
Progesterone—Erythema—Temozolomide—skin cancer	0.000194	0.000871	CcSEcCtD
Progesterone—Malnutrition—Temozolomide—skin cancer	0.000194	0.000871	CcSEcCtD
Progesterone—Breast disorder—Docetaxel—skin cancer	0.000194	0.00087	CcSEcCtD
Progesterone—Discomfort—Bleomycin—skin cancer	0.000194	0.000869	CcSEcCtD
Progesterone—Malaise—Dactinomycin—skin cancer	0.000193	0.000869	CcSEcCtD
Progesterone—Aspartate aminotransferase increased—Docetaxel—skin cancer	0.000193	0.000866	CcSEcCtD
Progesterone—Cramp muscle—Docetaxel—skin cancer	0.000193	0.000866	CcSEcCtD
Progesterone—Nasopharyngitis—Docetaxel—skin cancer	0.000192	0.00086	CcSEcCtD
Progesterone—Asthenia—Imiquimod—skin cancer	0.00019	0.000851	CcSEcCtD
Progesterone—Confusional state—Bleomycin—skin cancer	0.000189	0.00085	CcSEcCtD
Progesterone—Alanine aminotransferase increased—Docetaxel—skin cancer	0.000189	0.000849	CcSEcCtD
Progesterone—Anaphylactic shock—Bleomycin—skin cancer	0.000188	0.000843	CcSEcCtD
Progesterone—Oedema—Bleomycin—skin cancer	0.000188	0.000843	CcSEcCtD
Progesterone—Back pain—Temozolomide—skin cancer	0.000188	0.000843	CcSEcCtD
Progesterone—Pruritus—Imiquimod—skin cancer	0.000187	0.00084	CcSEcCtD
Progesterone—Infection—Bleomycin—skin cancer	0.000187	0.000838	CcSEcCtD
Progesterone—Dysphagia—Docetaxel—skin cancer	0.000185	0.000832	CcSEcCtD
Progesterone—Nausea—Vemurafenib—skin cancer	0.000184	0.000827	CcSEcCtD
Progesterone—ABCB1—mammalian vulva—skin cancer	0.000184	0.0029	CbGeAlD
Progesterone—CYP2D6—head—skin cancer	0.000183	0.00288	CbGeAlD
Progesterone—Vision blurred—Temozolomide—skin cancer	0.000183	0.000821	CcSEcCtD
Progesterone—Myalgia—Dactinomycin—skin cancer	0.000183	0.00082	CcSEcCtD
Progesterone—Tremor—Temozolomide—skin cancer	0.000182	0.000816	CcSEcCtD
Progesterone—Alopecia—Fluorouracil—skin cancer	0.000182	0.000815	CcSEcCtD
Progesterone—Diarrhoea—Imiquimod—skin cancer	0.000181	0.000812	CcSEcCtD
Progesterone—Discomfort—Dactinomycin—skin cancer	0.00018	0.00081	CcSEcCtD
Progesterone—Angina pectoris—Docetaxel—skin cancer	0.00018	0.00081	CcSEcCtD
Progesterone—Ill-defined disorder—Temozolomide—skin cancer	0.00018	0.000809	CcSEcCtD
Progesterone—Anaemia—Temozolomide—skin cancer	0.000179	0.000805	CcSEcCtD
Progesterone—Anorexia—Bleomycin—skin cancer	0.000179	0.000804	CcSEcCtD
Progesterone—Erythema—Fluorouracil—skin cancer	0.000179	0.000803	CcSEcCtD
Progesterone—CYP1A1—lymph node—skin cancer	0.000178	0.0028	CbGeAlD
Progesterone—Angioedema—Temozolomide—skin cancer	0.000177	0.000796	CcSEcCtD
Progesterone—Hypotension—Bleomycin—skin cancer	0.000175	0.000788	CcSEcCtD
Progesterone—Oedema—Dactinomycin—skin cancer	0.000175	0.000786	CcSEcCtD
Progesterone—Malaise—Temozolomide—skin cancer	0.000175	0.000786	CcSEcCtD
Progesterone—Dizziness—Imiquimod—skin cancer	0.000175	0.000785	CcSEcCtD
Progesterone—Vertigo—Temozolomide—skin cancer	0.000174	0.000783	CcSEcCtD
Progesterone—Infection—Dactinomycin—skin cancer	0.000174	0.000781	CcSEcCtD
Progesterone—NR3C1—lymph node—skin cancer	0.000172	0.00271	CbGeAlD
Progesterone—Palpitations—Temozolomide—skin cancer	0.000171	0.00077	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000171	0.000768	CcSEcCtD
Progesterone—Cough—Temozolomide—skin cancer	0.000169	0.00076	CcSEcCtD
Progesterone—Paraesthesia—Bleomycin—skin cancer	0.000169	0.000757	CcSEcCtD
Progesterone—Weight increased—Docetaxel—skin cancer	0.000169	0.000757	CcSEcCtD
Progesterone—Vision blurred—Fluorouracil—skin cancer	0.000169	0.000757	CcSEcCtD
Progesterone—Convulsion—Temozolomide—skin cancer	0.000168	0.000755	CcSEcCtD
Progesterone—Vomiting—Imiquimod—skin cancer	0.000168	0.000755	CcSEcCtD
Progesterone—Weight decreased—Docetaxel—skin cancer	0.000168	0.000752	CcSEcCtD
Progesterone—Hypertension—Temozolomide—skin cancer	0.000168	0.000752	CcSEcCtD
Progesterone—Dyspnoea—Bleomycin—skin cancer	0.000167	0.000752	CcSEcCtD
Progesterone—Anorexia—Dactinomycin—skin cancer	0.000167	0.000749	CcSEcCtD
Progesterone—Rash—Imiquimod—skin cancer	0.000167	0.000748	CcSEcCtD
Progesterone—Dermatitis—Imiquimod—skin cancer	0.000166	0.000748	CcSEcCtD
Progesterone—Pneumonia—Docetaxel—skin cancer	0.000166	0.000746	CcSEcCtD
Progesterone—Headache—Imiquimod—skin cancer	0.000166	0.000743	CcSEcCtD
Progesterone—Anaemia—Fluorouracil—skin cancer	0.000165	0.000742	CcSEcCtD
Progesterone—Arthralgia—Temozolomide—skin cancer	0.000165	0.000742	CcSEcCtD
Progesterone—Myalgia—Temozolomide—skin cancer	0.000165	0.000742	CcSEcCtD
Progesterone—Infestation—Docetaxel—skin cancer	0.000165	0.000742	CcSEcCtD
Progesterone—Infestation NOS—Docetaxel—skin cancer	0.000165	0.000742	CcSEcCtD
Progesterone—Anxiety—Temozolomide—skin cancer	0.000165	0.000739	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000164	0.000737	CcSEcCtD
Progesterone—ABCB1—lymphoid tissue—skin cancer	0.000163	0.00257	CbGeAlD
Progesterone—Discomfort—Temozolomide—skin cancer	0.000163	0.000733	CcSEcCtD
Progesterone—Decreased appetite—Bleomycin—skin cancer	0.000163	0.000733	CcSEcCtD
Progesterone—Neuropathy peripheral—Docetaxel—skin cancer	0.000162	0.000727	CcSEcCtD
Progesterone—Dry mouth—Temozolomide—skin cancer	0.000162	0.000726	CcSEcCtD
Progesterone—Jaundice—Docetaxel—skin cancer	0.000161	0.000723	CcSEcCtD
Progesterone—Pain—Bleomycin—skin cancer	0.000161	0.000721	CcSEcCtD
Progesterone—Conjunctivitis—Docetaxel—skin cancer	0.000161	0.000721	CcSEcCtD
Progesterone—Confusional state—Temozolomide—skin cancer	0.00016	0.000717	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00016	0.000716	CcSEcCtD
Progesterone—Oedema—Temozolomide—skin cancer	0.000158	0.000711	CcSEcCtD
Progesterone—Anaphylactic shock—Temozolomide—skin cancer	0.000158	0.000711	CcSEcCtD
Progesterone—ABCB1—female reproductive system—skin cancer	0.000158	0.00248	CbGeAlD
Progesterone—Infection—Temozolomide—skin cancer	0.000157	0.000707	CcSEcCtD
Progesterone—Nausea—Imiquimod—skin cancer	0.000157	0.000705	CcSEcCtD
Progesterone—Hepatobiliary disease—Docetaxel—skin cancer	0.000156	0.000701	CcSEcCtD
Progesterone—Nervous system disorder—Temozolomide—skin cancer	0.000155	0.000697	CcSEcCtD
Progesterone—Convulsion—Fluorouracil—skin cancer	0.000155	0.000696	CcSEcCtD
Progesterone—Feeling abnormal—Bleomycin—skin cancer	0.000155	0.000695	CcSEcCtD
Progesterone—Skin disorder—Temozolomide—skin cancer	0.000154	0.000691	CcSEcCtD
Progesterone—Hyperhidrosis—Temozolomide—skin cancer	0.000153	0.000688	CcSEcCtD
Progesterone—Chest pain—Fluorouracil—skin cancer	0.000152	0.000684	CcSEcCtD
Progesterone—Myalgia—Fluorouracil—skin cancer	0.000152	0.000684	CcSEcCtD
Progesterone—Decreased appetite—Dactinomycin—skin cancer	0.000152	0.000684	CcSEcCtD
Progesterone—Fatigue—Dactinomycin—skin cancer	0.000151	0.000678	CcSEcCtD
Progesterone—Anorexia—Temozolomide—skin cancer	0.000151	0.000678	CcSEcCtD
Progesterone—Discomfort—Fluorouracil—skin cancer	0.00015	0.000675	CcSEcCtD
Progesterone—Pain—Dactinomycin—skin cancer	0.00015	0.000672	CcSEcCtD
Progesterone—Urticaria—Bleomycin—skin cancer	0.000149	0.00067	CcSEcCtD
Progesterone—Haemoglobin—Docetaxel—skin cancer	0.000149	0.000669	CcSEcCtD
Progesterone—Rhinitis—Docetaxel—skin cancer	0.000149	0.000667	CcSEcCtD
Progesterone—Body temperature increased—Bleomycin—skin cancer	0.000148	0.000666	CcSEcCtD
Progesterone—Haemorrhage—Docetaxel—skin cancer	0.000148	0.000666	CcSEcCtD
Progesterone—Hepatitis—Docetaxel—skin cancer	0.000148	0.000666	CcSEcCtD
Progesterone—Confusional state—Fluorouracil—skin cancer	0.000147	0.000661	CcSEcCtD
Progesterone—Pharyngitis—Docetaxel—skin cancer	0.000147	0.000661	CcSEcCtD
Progesterone—Urinary tract disorder—Docetaxel—skin cancer	0.000146	0.000657	CcSEcCtD
Progesterone—Oedema peripheral—Docetaxel—skin cancer	0.000146	0.000656	CcSEcCtD
Progesterone—Anaphylactic shock—Fluorouracil—skin cancer	0.000146	0.000655	CcSEcCtD
Progesterone—Oedema—Fluorouracil—skin cancer	0.000146	0.000655	CcSEcCtD
Progesterone—Connective tissue disorder—Docetaxel—skin cancer	0.000146	0.000654	CcSEcCtD
Progesterone—Urethral disorder—Docetaxel—skin cancer	0.000145	0.000653	CcSEcCtD
Progesterone—Infection—Fluorouracil—skin cancer	0.000145	0.000651	CcSEcCtD
Progesterone—Feeling abnormal—Dactinomycin—skin cancer	0.000144	0.000648	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000144	0.000648	CcSEcCtD
Progesterone—Insomnia—Temozolomide—skin cancer	0.000143	0.000643	CcSEcCtD
Progesterone—Gastrointestinal pain—Dactinomycin—skin cancer	0.000143	0.000643	CcSEcCtD
Progesterone—Nervous system disorder—Fluorouracil—skin cancer	0.000143	0.000643	CcSEcCtD
Progesterone—Visual impairment—Docetaxel—skin cancer	0.000143	0.000642	CcSEcCtD
Progesterone—Tachycardia—Fluorouracil—skin cancer	0.000142	0.00064	CcSEcCtD
Progesterone—Paraesthesia—Temozolomide—skin cancer	0.000142	0.000639	CcSEcCtD
Progesterone—Dyspnoea—Temozolomide—skin cancer	0.000141	0.000634	CcSEcCtD
Progesterone—Somnolence—Temozolomide—skin cancer	0.000141	0.000632	CcSEcCtD
Progesterone—Erythema multiforme—Docetaxel—skin cancer	0.00014	0.000629	CcSEcCtD
Progesterone—Dyspepsia—Temozolomide—skin cancer	0.000139	0.000626	CcSEcCtD
Progesterone—Anorexia—Fluorouracil—skin cancer	0.000139	0.000625	CcSEcCtD
Progesterone—Eye disorder—Docetaxel—skin cancer	0.000139	0.000622	CcSEcCtD
Progesterone—Abdominal pain—Dactinomycin—skin cancer	0.000138	0.000622	CcSEcCtD
Progesterone—Body temperature increased—Dactinomycin—skin cancer	0.000138	0.000622	CcSEcCtD
Progesterone—Hypersensitivity—Bleomycin—skin cancer	0.000138	0.000621	CcSEcCtD
Progesterone—Decreased appetite—Temozolomide—skin cancer	0.000138	0.000618	CcSEcCtD
Progesterone—Cardiac disorder—Docetaxel—skin cancer	0.000138	0.000618	CcSEcCtD
Progesterone—Gastrointestinal disorder—Temozolomide—skin cancer	0.000137	0.000614	CcSEcCtD
Progesterone—Fatigue—Temozolomide—skin cancer	0.000137	0.000613	CcSEcCtD
Progesterone—Hypotension—Fluorouracil—skin cancer	0.000136	0.000612	CcSEcCtD
Progesterone—Pain—Temozolomide—skin cancer	0.000135	0.000608	CcSEcCtD
Progesterone—Constipation—Temozolomide—skin cancer	0.000135	0.000608	CcSEcCtD
Progesterone—Asthenia—Bleomycin—skin cancer	0.000135	0.000605	CcSEcCtD
Progesterone—Angiopathy—Docetaxel—skin cancer	0.000135	0.000604	CcSEcCtD
Progesterone—Immune system disorder—Docetaxel—skin cancer	0.000134	0.000601	CcSEcCtD
Progesterone—Mediastinal disorder—Docetaxel—skin cancer	0.000134	0.0006	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000133	0.000597	CcSEcCtD
Progesterone—Pruritus—Bleomycin—skin cancer	0.000133	0.000596	CcSEcCtD
Progesterone—Insomnia—Fluorouracil—skin cancer	0.000132	0.000593	CcSEcCtD
Progesterone—ABCB1—head—skin cancer	0.000132	0.00207	CbGeAlD
Progesterone—Paraesthesia—Fluorouracil—skin cancer	0.000131	0.000588	CcSEcCtD
Progesterone—Alopecia—Docetaxel—skin cancer	0.000131	0.000588	CcSEcCtD
Progesterone—Feeling abnormal—Temozolomide—skin cancer	0.000131	0.000586	CcSEcCtD
Progesterone—Dyspnoea—Fluorouracil—skin cancer	0.00013	0.000584	CcSEcCtD
Progesterone—Mental disorder—Docetaxel—skin cancer	0.00013	0.000583	CcSEcCtD
Progesterone—Somnolence—Fluorouracil—skin cancer	0.00013	0.000583	CcSEcCtD
Progesterone—Gastrointestinal pain—Temozolomide—skin cancer	0.00013	0.000582	CcSEcCtD
Progesterone—Erythema—Docetaxel—skin cancer	0.000129	0.000579	CcSEcCtD
Progesterone—Malnutrition—Docetaxel—skin cancer	0.000129	0.000579	CcSEcCtD
Progesterone—Hypersensitivity—Dactinomycin—skin cancer	0.000129	0.000579	CcSEcCtD
Progesterone—Dyspepsia—Fluorouracil—skin cancer	0.000128	0.000577	CcSEcCtD
Progesterone—Decreased appetite—Fluorouracil—skin cancer	0.000127	0.00057	CcSEcCtD
Progesterone—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000126	0.000566	CcSEcCtD
Progesterone—Urticaria—Temozolomide—skin cancer	0.000126	0.000565	CcSEcCtD
Progesterone—Asthenia—Dactinomycin—skin cancer	0.000126	0.000564	CcSEcCtD
Progesterone—Abdominal pain—Temozolomide—skin cancer	0.000125	0.000562	CcSEcCtD
Progesterone—Body temperature increased—Temozolomide—skin cancer	0.000125	0.000562	CcSEcCtD
Progesterone—Back pain—Docetaxel—skin cancer	0.000125	0.000561	CcSEcCtD
Progesterone—Pain—Fluorouracil—skin cancer	0.000125	0.00056	CcSEcCtD
Progesterone—Muscle spasms—Docetaxel—skin cancer	0.000124	0.000557	CcSEcCtD
Progesterone—Feeling abnormal—Fluorouracil—skin cancer	0.00012	0.00054	CcSEcCtD
Progesterone—Diarrhoea—Dactinomycin—skin cancer	0.00012	0.000538	CcSEcCtD
Progesterone—Vomiting—Bleomycin—skin cancer	0.000119	0.000536	CcSEcCtD
Progesterone—Anaemia—Docetaxel—skin cancer	0.000119	0.000536	CcSEcCtD
Progesterone—Rash—Bleomycin—skin cancer	0.000118	0.000532	CcSEcCtD
Progesterone—Dermatitis—Bleomycin—skin cancer	0.000118	0.000531	CcSEcCtD
Progesterone—Hypersensitivity—Temozolomide—skin cancer	0.000117	0.000524	CcSEcCtD
Progesterone—Urticaria—Fluorouracil—skin cancer	0.000116	0.000521	CcSEcCtD
Progesterone—Syncope—Docetaxel—skin cancer	0.000116	0.00052	CcSEcCtD
Progesterone—Body temperature increased—Fluorouracil—skin cancer	0.000115	0.000518	CcSEcCtD
Progesterone—Palpitations—Docetaxel—skin cancer	0.000114	0.000512	CcSEcCtD
Progesterone—Asthenia—Temozolomide—skin cancer	0.000114	0.00051	CcSEcCtD
Progesterone—Loss of consciousness—Docetaxel—skin cancer	0.000113	0.000509	CcSEcCtD
Progesterone—Cough—Docetaxel—skin cancer	0.000113	0.000506	CcSEcCtD
Progesterone—Pruritus—Temozolomide—skin cancer	0.000112	0.000503	CcSEcCtD
Progesterone—Convulsion—Docetaxel—skin cancer	0.000112	0.000502	CcSEcCtD
Progesterone—Nausea—Bleomycin—skin cancer	0.000112	0.000501	CcSEcCtD
Progesterone—Hypertension—Docetaxel—skin cancer	0.000111	0.0005	CcSEcCtD
Progesterone—Vomiting—Dactinomycin—skin cancer	0.000111	0.0005	CcSEcCtD
Progesterone—Rash—Dactinomycin—skin cancer	0.00011	0.000496	CcSEcCtD
Progesterone—Chest pain—Docetaxel—skin cancer	0.00011	0.000493	CcSEcCtD
Progesterone—Myalgia—Docetaxel—skin cancer	0.00011	0.000493	CcSEcCtD
Progesterone—Arthralgia—Docetaxel—skin cancer	0.00011	0.000493	CcSEcCtD
Progesterone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000109	0.00049	CcSEcCtD
Progesterone—Diarrhoea—Temozolomide—skin cancer	0.000108	0.000487	CcSEcCtD
Progesterone—Hypersensitivity—Fluorouracil—skin cancer	0.000108	0.000483	CcSEcCtD
Progesterone—Dry mouth—Docetaxel—skin cancer	0.000107	0.000482	CcSEcCtD
Progesterone—Confusional state—Docetaxel—skin cancer	0.000106	0.000477	CcSEcCtD
Progesterone—Oedema—Docetaxel—skin cancer	0.000105	0.000473	CcSEcCtD
Progesterone—Anaphylactic shock—Docetaxel—skin cancer	0.000105	0.000473	CcSEcCtD
Progesterone—Dizziness—Temozolomide—skin cancer	0.000105	0.00047	CcSEcCtD
Progesterone—Infection—Docetaxel—skin cancer	0.000105	0.00047	CcSEcCtD
Progesterone—Nausea—Dactinomycin—skin cancer	0.000104	0.000467	CcSEcCtD
Progesterone—Shock—Docetaxel—skin cancer	0.000104	0.000465	CcSEcCtD
Progesterone—Nervous system disorder—Docetaxel—skin cancer	0.000103	0.000464	CcSEcCtD
Progesterone—Pruritus—Fluorouracil—skin cancer	0.000103	0.000464	CcSEcCtD
Progesterone—Tachycardia—Docetaxel—skin cancer	0.000103	0.000462	CcSEcCtD
Progesterone—Skin disorder—Docetaxel—skin cancer	0.000102	0.000459	CcSEcCtD
Progesterone—Vomiting—Temozolomide—skin cancer	0.000101	0.000452	CcSEcCtD
Progesterone—Anorexia—Docetaxel—skin cancer	0.0001	0.000451	CcSEcCtD
Progesterone—Rash—Temozolomide—skin cancer	9.99e-05	0.000448	CcSEcCtD
Progesterone—Diarrhoea—Fluorouracil—skin cancer	9.98e-05	0.000448	CcSEcCtD
Progesterone—Dermatitis—Temozolomide—skin cancer	9.98e-05	0.000448	CcSEcCtD
Progesterone—Headache—Temozolomide—skin cancer	9.92e-05	0.000446	CcSEcCtD
Progesterone—Hypotension—Docetaxel—skin cancer	9.84e-05	0.000442	CcSEcCtD
Progesterone—Dizziness—Fluorouracil—skin cancer	9.65e-05	0.000433	CcSEcCtD
Progesterone—Musculoskeletal discomfort—Docetaxel—skin cancer	9.6e-05	0.000431	CcSEcCtD
Progesterone—Insomnia—Docetaxel—skin cancer	9.53e-05	0.000428	CcSEcCtD
Progesterone—Paraesthesia—Docetaxel—skin cancer	9.46e-05	0.000425	CcSEcCtD
Progesterone—Nausea—Temozolomide—skin cancer	9.41e-05	0.000422	CcSEcCtD
Progesterone—Dyspnoea—Docetaxel—skin cancer	9.39e-05	0.000422	CcSEcCtD
Progesterone—Somnolence—Docetaxel—skin cancer	9.36e-05	0.00042	CcSEcCtD
Progesterone—Vomiting—Fluorouracil—skin cancer	9.28e-05	0.000417	CcSEcCtD
Progesterone—Dyspepsia—Docetaxel—skin cancer	9.27e-05	0.000416	CcSEcCtD
Progesterone—ABCB1—lymph node—skin cancer	9.22e-05	0.00145	CbGeAlD
Progesterone—Rash—Fluorouracil—skin cancer	9.2e-05	0.000413	CcSEcCtD
Progesterone—Dermatitis—Fluorouracil—skin cancer	9.19e-05	0.000413	CcSEcCtD
Progesterone—Decreased appetite—Docetaxel—skin cancer	9.16e-05	0.000411	CcSEcCtD
Progesterone—Headache—Fluorouracil—skin cancer	9.14e-05	0.00041	CcSEcCtD
Progesterone—Gastrointestinal disorder—Docetaxel—skin cancer	9.09e-05	0.000408	CcSEcCtD
Progesterone—Fatigue—Docetaxel—skin cancer	9.08e-05	0.000408	CcSEcCtD
Progesterone—Constipation—Docetaxel—skin cancer	9.01e-05	0.000404	CcSEcCtD
Progesterone—Pain—Docetaxel—skin cancer	9.01e-05	0.000404	CcSEcCtD
Progesterone—Feeling abnormal—Docetaxel—skin cancer	8.68e-05	0.00039	CcSEcCtD
Progesterone—Nausea—Fluorouracil—skin cancer	8.67e-05	0.000389	CcSEcCtD
Progesterone—Gastrointestinal pain—Docetaxel—skin cancer	8.61e-05	0.000387	CcSEcCtD
Progesterone—Body temperature increased—Docetaxel—skin cancer	8.33e-05	0.000374	CcSEcCtD
Progesterone—Abdominal pain—Docetaxel—skin cancer	8.33e-05	0.000374	CcSEcCtD
Progesterone—Hypersensitivity—Docetaxel—skin cancer	7.76e-05	0.000348	CcSEcCtD
Progesterone—Asthenia—Docetaxel—skin cancer	7.56e-05	0.000339	CcSEcCtD
Progesterone—Pruritus—Docetaxel—skin cancer	7.45e-05	0.000335	CcSEcCtD
Progesterone—Diarrhoea—Docetaxel—skin cancer	7.21e-05	0.000324	CcSEcCtD
Progesterone—Dizziness—Docetaxel—skin cancer	6.97e-05	0.000313	CcSEcCtD
Progesterone—Vomiting—Docetaxel—skin cancer	6.7e-05	0.000301	CcSEcCtD
Progesterone—Rash—Docetaxel—skin cancer	6.64e-05	0.000298	CcSEcCtD
Progesterone—Dermatitis—Docetaxel—skin cancer	6.63e-05	0.000298	CcSEcCtD
Progesterone—Headache—Docetaxel—skin cancer	6.6e-05	0.000296	CcSEcCtD
Progesterone—Nausea—Docetaxel—skin cancer	6.26e-05	0.000281	CcSEcCtD
Progesterone—SLC22A1—Transmembrane transport of small molecules—SLC12A2—skin cancer	3.29e-05	0.00209	CbGpPWpGaD
Progesterone—ESR1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	3.29e-05	0.00209	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RHOU—skin cancer	3.28e-05	0.00208	CbGpPWpGaD
Progesterone—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	3.28e-05	0.00208	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—CDK4—skin cancer	3.12e-05	0.00198	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—skin cancer	2.98e-05	0.00189	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—NRAS—skin cancer	2.94e-05	0.00187	CbGpPWpGaD
Progesterone—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	2.93e-05	0.00186	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—MC1R—skin cancer	2.88e-05	0.00183	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	2.81e-05	0.00178	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PLIN2—skin cancer	2.78e-05	0.00177	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—BRAF—skin cancer	2.76e-05	0.00175	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTCH2—skin cancer	2.73e-05	0.00173	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.68e-05	0.0017	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—CSPG4—skin cancer	2.68e-05	0.0017	CbGpPWpGaD
Progesterone—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	2.67e-05	0.0017	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PLIN2—skin cancer	2.67e-05	0.00169	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	2.66e-05	0.00169	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—MC1R—skin cancer	2.62e-05	0.00166	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.59e-05	0.00164	CbGpPWpGaD
Progesterone—ESR1—ATF-2 transcription factor network—IL6—skin cancer	2.58e-05	0.00164	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—KRAS—skin cancer	2.56e-05	0.00163	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—KRAS—skin cancer	2.53e-05	0.00161	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—ENO2—skin cancer	2.48e-05	0.00157	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.46e-05	0.00156	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—TP53—skin cancer	2.46e-05	0.00156	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—skin cancer	2.44e-05	0.00155	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—TP53—skin cancer	2.42e-05	0.00154	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	2.4e-05	0.00152	CbGpPWpGaD
Progesterone—CYP1A2—Arachidonic acid metabolism—PTGS2—skin cancer	2.28e-05	0.00145	CbGpPWpGaD
Progesterone—ESR1—AP-1 transcription factor network—IL6—skin cancer	2.25e-05	0.00143	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—CSPG4—skin cancer	2.24e-05	0.00142	CbGpPWpGaD
Progesterone—ESR1—Leptin signaling pathway—HRAS—skin cancer	2.22e-05	0.00141	CbGpPWpGaD
Progesterone—NR3C1—AP-1 transcription factor network—IL6—skin cancer	2.22e-05	0.00141	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.19e-05	0.00139	CbGpPWpGaD
Progesterone—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—skin cancer	2.18e-05	0.00138	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—HRAS—skin cancer	2.15e-05	0.00137	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—CSPG4—skin cancer	2.15e-05	0.00137	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTCH2—skin cancer	2.14e-05	0.00136	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—BRAF—skin cancer	2.14e-05	0.00136	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—TP53—skin cancer	2.13e-05	0.00135	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—GLI2—skin cancer	2.07e-05	0.00131	CbGpPWpGaD
Progesterone—NR3C2—Gene Expression—ERCC2—skin cancer	2.06e-05	0.00131	CbGpPWpGaD
Progesterone—PGR—Signaling by ERBB4—IL6—skin cancer	2.06e-05	0.00131	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PLIN2—skin cancer	2e-05	0.00127	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2e-05	0.00127	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—BRAF—skin cancer	1.99e-05	0.00126	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—MC1R—skin cancer	1.97e-05	0.00125	CbGpPWpGaD
Progesterone—NR3C1—Glucocorticoid receptor regulatory network—IL6—skin cancer	1.95e-05	0.00124	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—GLI1—skin cancer	1.95e-05	0.00124	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.94e-05	0.00123	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.94e-05	0.00123	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PLIN2—skin cancer	1.94e-05	0.00123	CbGpPWpGaD
Progesterone—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.93e-05	0.00123	CbGpPWpGaD
Progesterone—ABCC1—Disease—CSPG4—skin cancer	1.93e-05	0.00122	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—skin cancer	1.9e-05	0.00121	CbGpPWpGaD
Progesterone—OPRK1—GPCR downstream signaling—PTGER4—skin cancer	1.9e-05	0.0012	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—SHH—skin cancer	1.87e-05	0.00118	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.85e-05	0.00117	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SUFU—skin cancer	1.85e-05	0.00117	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ENO2—skin cancer	1.82e-05	0.00116	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PTCH1—skin cancer	1.77e-05	0.00112	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—SMO—skin cancer	1.77e-05	0.00112	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PLIN2—skin cancer	1.75e-05	0.00111	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PLIN2—skin cancer	1.75e-05	0.00111	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—NRAS—skin cancer	1.73e-05	0.0011	CbGpPWpGaD
Progesterone—AR—Integrated Breast Cancer Pathway—TP53—skin cancer	1.72e-05	0.00109	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—PTGER4—skin cancer	1.72e-05	0.00109	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.71e-05	0.00109	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—BRAF—skin cancer	1.64e-05	0.00104	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—skin cancer	1.63e-05	0.00104	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PLIN2—skin cancer	1.63e-05	0.00103	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GLI2—skin cancer	1.62e-05	0.00103	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—CSPG4—skin cancer	1.62e-05	0.00103	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.61e-05	0.00102	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH2—skin cancer	1.6e-05	0.00102	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PLIN2—skin cancer	1.6e-05	0.00102	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—CSPG4—skin cancer	1.56e-05	0.000992	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—MC1R—skin cancer	1.55e-05	0.000982	CbGpPWpGaD
Progesterone—AR—SIDS Susceptibility Pathways—IL6—skin cancer	1.54e-05	0.000976	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—BRAF—skin cancer	1.53e-05	0.000969	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ENO2—skin cancer	1.53e-05	0.000968	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—GLI1—skin cancer	1.52e-05	0.000968	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—KRAS—skin cancer	1.49e-05	0.000949	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—KRAS—skin cancer	1.49e-05	0.000944	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ENO2—skin cancer	1.46e-05	0.000928	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SUFU—skin cancer	1.45e-05	0.000917	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—ERCC2—skin cancer	1.44e-05	0.000915	CbGpPWpGaD
Progesterone—AR—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.43e-05	0.000907	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.42e-05	0.000904	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—CSPG4—skin cancer	1.41e-05	0.000895	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—CSPG4—skin cancer	1.41e-05	0.000893	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SHH—skin cancer	1.41e-05	0.000893	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—RASA1—skin cancer	1.4e-05	0.000888	CbGpPWpGaD
Progesterone—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—skin cancer	1.39e-05	0.000882	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	1.37e-05	0.000869	CbGpPWpGaD
Progesterone—NR3C1—Adipogenesis—IL6—skin cancer	1.35e-05	0.000857	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTCH1—skin cancer	1.33e-05	0.000847	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—SMO—skin cancer	1.33e-05	0.000847	CbGpPWpGaD
Progesterone—ESR1—Integrated Breast Cancer Pathway—TP53—skin cancer	1.33e-05	0.000843	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—CSPG4—skin cancer	1.31e-05	0.000833	CbGpPWpGaD
Progesterone—ABCC1—Disease—ENO2—skin cancer	1.31e-05	0.000833	CbGpPWpGaD
Progesterone—ABCC1—Disease—SHH—skin cancer	1.31e-05	0.000833	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—PTGER4—skin cancer	1.3e-05	0.000824	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—CSPG4—skin cancer	1.29e-05	0.00082	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—HRAS—skin cancer	1.26e-05	0.000802	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PLIN2—skin cancer	1.26e-05	0.000802	CbGpPWpGaD
Progesterone—PGR—Gene Expression—ERCC2—skin cancer	1.26e-05	0.000798	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.24e-05	0.000786	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GLI2—skin cancer	1.21e-05	0.000771	CbGpPWpGaD
Progesterone—ESR1—Signaling by ERBB4—IL6—skin cancer	1.21e-05	0.000768	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PLIN2—skin cancer	1.19e-05	0.000758	CbGpPWpGaD
Progesterone—NR3C1—SIDS Susceptibility Pathways—IL6—skin cancer	1.17e-05	0.000741	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—MC1R—skin cancer	1.16e-05	0.000736	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—FOXO4—skin cancer	1.15e-05	0.000728	CbGpPWpGaD
Progesterone—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.14e-05	0.000726	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—GLI1—skin cancer	1.14e-05	0.000725	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SHH—skin cancer	1.1e-05	0.0007	CbGpPWpGaD
Progesterone—ESR1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.1e-05	0.000699	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ENO2—skin cancer	1.1e-05	0.000697	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—RASA1—skin cancer	1.1e-05	0.000695	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PLIN2—skin cancer	1.09e-05	0.000695	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SUFU—skin cancer	1.08e-05	0.000687	CbGpPWpGaD
Progesterone—ABCC1—Disease—FOXO4—skin cancer	1.07e-05	0.000679	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ENO2—skin cancer	1.06e-05	0.000674	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—ERCC2—skin cancer	1.06e-05	0.000671	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTCH1—skin cancer	1.04e-05	0.000663	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—SMO—skin cancer	1.04e-05	0.000663	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—CSPG4—skin cancer	1.02e-05	0.000647	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—PTGER4—skin cancer	1.02e-05	0.000646	CbGpPWpGaD
Progesterone—SLC22A2—Transmission across Chemical Synapses—HRAS—skin cancer	9.83e-06	0.000624	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	9.79e-06	0.000621	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PLIN2—skin cancer	9.77e-06	0.00062	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—CSPG4—skin cancer	9.63e-06	0.000611	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ENO2—skin cancer	9.58e-06	0.000608	CbGpPWpGaD
Progesterone—AR—Gene Expression—ERCC2—skin cancer	9.58e-06	0.000608	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ENO2—skin cancer	9.57e-06	0.000607	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PLIN2—skin cancer	9.54e-06	0.000605	CbGpPWpGaD
Progesterone—SLC22A1—Transmission across Chemical Synapses—HRAS—skin cancer	9.16e-06	0.000582	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PLIN2—skin cancer	8.99e-06	0.000571	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—FOXO4—skin cancer	8.98e-06	0.00057	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ENO2—skin cancer	8.92e-06	0.000566	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PLIN2—skin cancer	8.91e-06	0.000566	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—ERCC2—skin cancer	8.86e-06	0.000562	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—CSPG4—skin cancer	8.82e-06	0.00056	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ENO2—skin cancer	8.78e-06	0.000557	CbGpPWpGaD
Progesterone—SLC10A1—Metabolism—PTGS2—skin cancer	8.64e-06	0.000549	CbGpPWpGaD
Progesterone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.59e-06	0.000545	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—ERCC2—skin cancer	8.49e-06	0.000539	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	8.31e-06	0.000527	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SHH—skin cancer	8.26e-06	0.000524	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—RASA1—skin cancer	8.21e-06	0.000521	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—CSPG4—skin cancer	7.88e-06	0.0005	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—SMO—skin cancer	7.83e-06	0.000497	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTCH1—skin cancer	7.83e-06	0.000497	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—CSPG4—skin cancer	7.69e-06	0.000488	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TERT—skin cancer	7.66e-06	0.000486	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—PTGER4—skin cancer	7.62e-06	0.000484	CbGpPWpGaD
Progesterone—ABCC1—Disease—ERCC2—skin cancer	7.62e-06	0.000484	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PLIN2—skin cancer	7.61e-06	0.000483	CbGpPWpGaD
Progesterone—SLC22A2—Neuronal System—HRAS—skin cancer	7.53e-06	0.000478	CbGpPWpGaD
Progesterone—ESR1—Gene Expression—ERCC2—skin cancer	7.38e-06	0.000468	CbGpPWpGaD
Progesterone—NR3C1—Gene Expression—ERCC2—skin cancer	7.27e-06	0.000461	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—CSPG4—skin cancer	7.24e-06	0.00046	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—CSPG4—skin cancer	7.18e-06	0.000456	CbGpPWpGaD
Progesterone—ABCC1—Disease—TERT—skin cancer	7.14e-06	0.000453	CbGpPWpGaD
Progesterone—SLC22A1—Neuronal System—HRAS—skin cancer	7.02e-06	0.000446	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ENO2—skin cancer	6.93e-06	0.00044	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—FOXO4—skin cancer	6.73e-06	0.000427	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	6.55e-06	0.000416	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ENO2—skin cancer	6.54e-06	0.000415	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—ERCC2—skin cancer	6.38e-06	0.000405	CbGpPWpGaD
Progesterone—CYP17A1—Metabolism—PTGS2—skin cancer	6.34e-06	0.000403	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—ERCC2—skin cancer	6.17e-06	0.000392	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—CSPG4—skin cancer	6.14e-06	0.00039	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—BRAF—skin cancer	6.07e-06	0.000385	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TERT—skin cancer	6e-06	0.000381	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ENO2—skin cancer	6e-06	0.000381	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PLIN2—skin cancer	5.88e-06	0.000373	CbGpPWpGaD
Progesterone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	5.83e-06	0.00037	CbGpPWpGaD
Progesterone—ABCC1—Disease—BRAF—skin cancer	5.66e-06	0.000359	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—ERCC2—skin cancer	5.56e-06	0.000353	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—ERCC2—skin cancer	5.56e-06	0.000353	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ENO2—skin cancer	5.35e-06	0.00034	CbGpPWpGaD
Progesterone—SLC22A3—Metabolism—PTGS2—skin cancer	5.31e-06	0.000337	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ENO2—skin cancer	5.23e-06	0.000332	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—ERCC2—skin cancer	5.18e-06	0.000329	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.12e-06	0.000325	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—ERCC2—skin cancer	5.1e-06	0.000324	CbGpPWpGaD
Progesterone—ABCB11—Metabolism—PTGS2—skin cancer	5.09e-06	0.000323	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—NRAS—skin cancer	5.06e-06	0.000321	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ENO2—skin cancer	4.92e-06	0.000313	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ENO2—skin cancer	4.88e-06	0.00031	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—BRAF—skin cancer	4.75e-06	0.000302	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—CSPG4—skin cancer	4.74e-06	0.000301	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.69e-06	0.000298	CbGpPWpGaD
Progesterone—ABCC1—Disease—PTGS2—skin cancer	4.57e-06	0.00029	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TERT—skin cancer	4.5e-06	0.000285	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—KRAS—skin cancer	4.35e-06	0.000276	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.19e-06	0.000266	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ENO2—skin cancer	4.17e-06	0.000265	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—ERCC2—skin cancer	4.02e-06	0.000255	CbGpPWpGaD
Progesterone—ABCC1—Metabolism—PTGS2—skin cancer	3.83e-06	0.000243	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.82e-06	0.000242	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—NRAS—skin cancer	3.81e-06	0.000242	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—ERCC2—skin cancer	3.8e-06	0.000241	CbGpPWpGaD
Progesterone—CYP1B1—Metabolism—PTGS2—skin cancer	3.7e-06	0.000235	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—HRAS—skin cancer	3.7e-06	0.000235	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—BRAF—skin cancer	3.56e-06	0.000226	CbGpPWpGaD
Progesterone—ABCC1—Disease—NRAS—skin cancer	3.55e-06	0.000226	CbGpPWpGaD
Progesterone—OPRK1—Signaling by GPCR—IL6—skin cancer	3.54e-06	0.000225	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—ERCC2—skin cancer	3.48e-06	0.000221	CbGpPWpGaD
Progesterone—CYP3A7—Metabolism—PTGS2—skin cancer	3.34e-06	0.000212	CbGpPWpGaD
Progesterone—SLC22A2—Metabolism—PTGS2—skin cancer	3.33e-06	0.000212	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—KRAS—skin cancer	3.28e-06	0.000208	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.26e-06	0.000207	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ENO2—skin cancer	3.22e-06	0.000204	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—ERCC2—skin cancer	3.11e-06	0.000197	CbGpPWpGaD
Progesterone—SLC22A1—Metabolism—PTGS2—skin cancer	3.11e-06	0.000197	CbGpPWpGaD
Progesterone—ABCC1—Disease—KRAS—skin cancer	3.06e-06	0.000194	CbGpPWpGaD
Progesterone—CYP2A6—Metabolism—PTGS2—skin cancer	3.06e-06	0.000194	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—ERCC2—skin cancer	3.04e-06	0.000193	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—NRAS—skin cancer	2.99e-06	0.00019	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—TP53—skin cancer	2.92e-06	0.000185	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—ERCC2—skin cancer	2.86e-06	0.000182	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—ERCC2—skin cancer	2.84e-06	0.00018	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—HRAS—skin cancer	2.79e-06	0.000177	CbGpPWpGaD
Progesterone—PGR—Signaling Pathways—IL6—skin cancer	2.67e-06	0.00017	CbGpPWpGaD
Progesterone—ABCC1—Disease—HRAS—skin cancer	2.6e-06	0.000165	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—KRAS—skin cancer	2.57e-06	0.000163	CbGpPWpGaD
Progesterone—ABCC1—Disease—IL6—skin cancer	2.49e-06	0.000158	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—ERCC2—skin cancer	2.42e-06	0.000154	CbGpPWpGaD
Progesterone—CYP3A5—Metabolism—PTGS2—skin cancer	2.41e-06	0.000153	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—TP53—skin cancer	2.28e-06	0.000145	CbGpPWpGaD
Progesterone—CYP1A1—Metabolism—PTGS2—skin cancer	2.28e-06	0.000145	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—NRAS—skin cancer	2.24e-06	0.000142	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—HRAS—skin cancer	2.18e-06	0.000139	CbGpPWpGaD
Progesterone—OPRK1—Signaling Pathways—IL6—skin cancer	2.09e-06	0.000133	CbGpPWpGaD
Progesterone—CYP2C8—Metabolism—PTGS2—skin cancer	2.09e-06	0.000133	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—KRAS—skin cancer	1.93e-06	0.000122	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—ERCC2—skin cancer	1.87e-06	0.000119	CbGpPWpGaD
Progesterone—CYP2C19—Metabolism—PTGS2—skin cancer	1.86e-06	0.000118	CbGpPWpGaD
Progesterone—ABCB1—Metabolism—PTGS2—skin cancer	1.82e-06	0.000116	CbGpPWpGaD
Progesterone—CYP2D6—Metabolism—PTGS2—skin cancer	1.72e-06	0.000109	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—TP53—skin cancer	1.71e-06	0.000109	CbGpPWpGaD
Progesterone—CYP2C9—Metabolism—PTGS2—skin cancer	1.7e-06	0.000108	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—HRAS—skin cancer	1.64e-06	0.000104	CbGpPWpGaD
Progesterone—ESR1—Signaling Pathways—IL6—skin cancer	1.57e-06	9.95e-05	CbGpPWpGaD
Progesterone—CYP1A2—Metabolism—PTGS2—skin cancer	1.45e-06	9.22e-05	CbGpPWpGaD
Progesterone—CYP3A4—Metabolism—PTGS2—skin cancer	1.12e-06	7.12e-05	CbGpPWpGaD
